Browsing by Author BRUCHERTSEIFER FRANK

Showing results 1 to 20 of 80  next >
Publication YearJRC N°TitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2007JRC38225213bi-Induced Death of Hsc45-M2 Gastric Cancer Cells Is Characterized by G2 Arrest and Up-Regulation of Genes Known to Prevent Apoptosis but Induce Necrosis and Mitotic CatastrpopheSEIDL C.; PORT M.; GILBERTZ K.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; SCHWAIGER M.; ROEPER B.; SENEKOWITSCH-SCHMIDTKE R.; ABEND M.Articles in periodicals and books
2007JRC41950213Bi-radioimmunotherapy Defeats Early-stage Disseminated Gastric Cancer in Nude MiceBECK R.; SEIDL C.; PFOST B.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; BAUM M.; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.Articles in periodicals and books
2017JRC106139225Ac-DOTA-Substance P as a potential radiopharmaceutical for targeted alpha therapy of glioblastoma multiformeMAJKOWSKA PILIP AGNIESZKA; RIUS MONTRAVETA MARIA; BRUCHERTSEIFER FRANK; APOSTOLIDIS CHRISTOS; WEIS MIRJAM; BONELLI MILTON; LAURENZA MARTA; MORGENSTERN ALFREDArticles in periodicals and books
2019JRC116486225Ac-labeled girentuximab for targeted alpha therapy of CAIX-expressing renal cell cancer xenograftsMERKX ROBIN; HESKAMP SANDRA; MULDERS PETER; RIJPKEMA MARK; OOSTERWIJK EGBERT; WHEATCROFT MICHAEL; KIP ANNEMARIE; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANKArticles in periodicals and books
2019JRC116489225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancerSATHEKGE MIKE; BRUCHERTSEIFER FRANK; KNOESEN OTTO; REYNEKE F; LENGANA T; LAWAL I; BOSHOMANE T; MOKOALA K; VORSTER MARIZA; MORGENSTERN ALFREDArticles in periodicals and books
2018JRC111741225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot studySATHEKGE MIKE; BRUCHERTSEIFER FRANK; KNOESEN OTTO; REYNEKE F; LAWAL I; LENGANA T; DAVIS CINDY; MAHAPANE JOHNCY; CORBETT CECELIA; VORSTER MARIZA, et alArticles in periodicals and books
2017JRC106148225Ac-PSMA617: PSMA targeting alpha-radiation therapy of patients with mCRPCKRATOCHWIL CLEMENS; BRUCHERTSEIFER FRANK; GIESEL FREDERIK; APOSTOLIDIS CHRISTOS; HABERKORN UWE; MORGENSTERN ALFREDArticles in periodicals and books
2017JRC106137Assessing 225Ac-Polymersomes for Targeted Radionuclide TherapyDE KRUIJFF R. M.; HESKAMP SANDRA; VAN DER MEER A; KOUWENBERG J; TORRELO VILLA G; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; SMINIA P; DENKOVA A.G.Articles in periodicals and books
2019JRC111743Assessment of 213Bi-anti-EGFR MAb treatment efficacy in malignant cancer cells with [1-13C]pyruvate and [18F]FDGFEUERECKER BENEDIKT; MICHALIK MICHAEL; HUNDSHAMMER CHRISTIAN; SCHWAIGER M.; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; SEIDL C.Articles in periodicals and books
2017JRC105961Assessment of 213Bi-anti-EGFR-MAb treatment response in malignant cancer cellsFEUERECKER BENEDIKT; RANDL PHILIPP; SEIDL C.; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; SCHWAIGER M.; EISENREICH WOLFGANGArticles in periodicals and books
2017JRC105960Barium ferrite nanoparticles labeled with 223Ra: a new potential radiobioconjugate for internal alpha therapyMALISZEWSKA W; CĘDROWSKA E; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; BILEWICZ ALEKSANDERArticles in periodicals and books
2019JRC114229Barium ferrite magnetic nanoparticles labeled with 223Ra: a new potential magnetic radiobioconjugate for targeted alpha therapyBILEWICZ ALEKSANDER; CEDROWSKA EDYTA; GAWEDA W; BRUCHERTSEIFER FRANK; MORGENSTERN ALFREDArticles in periodicals and books
2018JRC111736Bi-213-anti-EGFR-MAb therapy of recurrent bladder cancerSCHEIDHAUER KLEMENS; SEIDL C.; AUTENRIETH M.; BRUCHERTSEIFER FRANK; APOSTOLIDIS CHRISTOS; KURTZ F; HORN THOMAS; PFOB C; SCHWAIGER M.; GSCHWEND J.E., et alArticles in periodicals and books
2017JRC106154Bi-213-anti-EGFR-MAb therapy of recurrent bladder cancer – a pilot studySCHEIDHAUER KLEMENS; SEIDL C.; BRUCHERTSEIFER FRANK; APOSTOLIDIS CHRISTOS; AUTENRIETH MICHAEL; KURTZ F; HORN THOMAS; SCHWAIGER MARKUS; GSCHWEND J.E.; D'ALESSANDRIA C, et alArticles in periodicals and books
2017JRC106724Bi-213-anti-EGFR-MAb therapy of recurrent bladder cancer – a pilot studySCHEIDHAUER KLEMENS; SEIDL C.; BRUCHERTSEIFER FRANK; APOSTOLIDIS CHRISTOS; AUTENRIETH M.; KURTZ F; HORN THOMAS; SCHWAIGER M.; GSCHWEND J.E.; D’ALESSANDRIA CALO, et alArticles in periodicals and books
2017JRC106150Biodistribution, dosimetry and imaging of 225Ac-DOTA-anti-PD-L1-BC in a murine immunocompetent transgenic breast cancer modelJOSEFSSON ANDERS; NEDROW JESSIE; PARK SUNJU; BAECK TOM; HOBBS ROBERT F.; BRAYTON CORY; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; SGOUROS G.Articles in periodicals and books
2019JRC116460Combining Bismuth-213 with Nanobodies: finding the perfect match for Targeted Alpha TherapyDEKEMPENEER YANA; CAVELIERS VICKY; D'HUYVETTER MATTHIAS; MAERTENS DOMINIC; GYSEMANS M.; OOMS MAARTEN; LAHOUTTE TONY; XAVIER CATHARINA; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED, et alArticles in periodicals and books
2019JRC116618Correlation between PSA response and response assessment with 68Ga-PSMA-11 PET/CT-derived metabolic parameters in patients treated with 225Ac-PSMA-617 for metastatic prostate carcinomaLAWAL I; MORGENSTERN ALFRED; KNOESEN OTTO; VORSTER MARIZA; POPOOLA GO; MAHAPANE JOHNCY; LENGANA T; BOSHOMANE T; MOKOALA K; BRUCHERTSEIFER FRANK, et alArticles in periodicals and books
2017JRC106151Correspondence between alpha-particle emitter dosimetry and normal organ toxicityJOSEFSSON ANDERS; NEDROW JESSIE; HOBBS ROBERT F.; BAECK TOM; PARK SUNJU; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; SGOUROS GEORGEArticles in periodicals and books
2019JRC113789Development and dosimetry of Pb-203 / Pb-212 labeled PSMA ligands – Bringing “the Lead” into PSMA-Targeting Alpha Therapy?KRATOCHWIL CLEMENS; DOS SANTOS JOSE CARLOS; LEHNERT WENCKE; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; HABERKORN UWE; KOPKA KLAUS; MIER WALTERArticles in periodicals and books